Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan 7;74(1):1.
doi: 10.1007/s00011-024-01972-8.

Targeting mitochondrial function as a potential therapeutic approach for allergic asthma

Daichi Chen  1 , Wanhua Wu  1 , Jianing Li  1 , Xueqin Huang  1 , Su Chen  2 , TingTing Zheng  1 , Gonghua Huang  1 , Suidong Ouyang  3   4
Affiliations
Review

Targeting mitochondrial function as a potential therapeutic approach for allergic asthma

Daichi Chen et al. Inflamm Res. .

Abstract

Allergic asthma is a chronic complex airway disease characterized by airway hyperresponsiveness, eosinophilic inflammation, excessive mucus secretion, and airway remodeling, with increasing mortality and incidence globally. The pathogenesis of allergic asthma is influenced by various factors including genetics, environment, and immune responses, making it complex and diverse. Recent studies have found that various cellular functions of mitochondria such as calcium regulation, adenosine triphosphate production, changes in redox potential, and free radical scavenging, are involved in regulating the pathogenesis of asthma. This review explores the involvement of mitochondrial functional changes in the pathogenesis of asthma, and investigate the potential of targeting cellular mitochondria as a therapeutic approach for asthma. Those insights can provide a novel theoretical foundations and treatment strategies for understanding and preventing asthma.

Keywords: Allergic asthma; Mitochondrial function; Pathogenesis; Therapeutic targets.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no conflict of interest.

References

    1. Hammad H, Lambrecht BN. The basic immunology of asthma. Cell. 2021;184:1469–85. - PubMed
    1. Gans MD, Gavrilova T. Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes. Paediatr Respir Rev. 2020;36:118–27. - PubMed
    1. Agache I, Eguiluz-Gracia I, Cojanu C, Laculiceanu A, Del Giacco S, Zemelka-Wiacek M, Kosowska A, Akdis CA, Jutel M. Advances and highlights in asthma in 2021. Allergy. 2021;76:3390–407. - PubMed
    1. Liu K, Hua S, Song L. PM2.5 exposure and asthma development: The key role of oxidative stress. Oxid Med Cell Longev. 2022;2022:3618806. - PubMed - PMC
    1. Michaeloudes C, Abubakar-Waziri H, Lakhdar R, Raby K, Dixey P, Adcock IM, Mumby S, Bhavsar PK, Chung KF. Molecular mechanisms of oxidative stress in asthma. Mol Asp Med. 2022;85: 101026.